All signals lost

Science Translational Medicine

Volumn 5, Issue 203, 2013, Pages

  Wilke, Kaelyn E ^a   Carlson, Erin E ^a  

^a INDIANA UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADENOSINE TRIPHOSPHATE; BACTERIAL PROTEIN; GELDANAMYCIN; HEAT SHOCK PROTEIN 90; NOVOBIOCIN; PHOP PROTEIN; PHOQ PROTEIN; PROTEIN HISTIDINE KINASE; RADICICOL; UNCLASSIFIED DRUG;

ANTIBIOTIC RESISTANCE; BACTERIAL SURVIVAL; BACTERIAL VIRULENCE; BINDING AFFINITY; DRUG DESIGN; DRUG SCREENING; DRUG TARGETING; ENZYME ACTIVE SITE; HIGH THROUGHPUT SCREENING; HUMAN; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; PRIORITY JOURNAL; PSEUDOMONAS AERUGINOSA; QUORUM SENSING; REVIEW; SALMONELLA TYPHIMURIUM; SHIGELLA FLEXNERI; STAPHYLOCOCCUS AUREUS; STAPHYLOCOCCUS INFECTION;

ANTI-BACTERIAL AGENTS; BACTERIAL PROTEINS; PROTEIN KINASE INHIBITORS; PROTEIN KINASES; SIGNAL TRANSDUCTION;

EID: 84884696537     PISSN: 19466234     EISSN: 19466242     Source Type: Journal    
DOI: 10.1126/scitranslmed.3006670     Document Type: Review

References (26)

1. A. M. Stock, V. L. Robinson, P. N. Goudreau, Two-component signal transduction. Annu. Rev. Biochem. 69, 183-215 (2000).
2. 2+ as an extracellular signal: Environmental regulation of Salmonella virulence. Cell 84, 165-174 (1996).
3. Y. Gotoh, Y. Eguchi, T. Watanabe, S. Okamoto, A. Doi, R. Utsumi, Two-component signal transduction as potential drug targets in pathogenic bacteria. Curr. Opin. Microbiol. 13, 232-239 (2010).
4. A. L. Goodman, B. Kulasekara, A. Rietsch, D. Boyd, R. S. Smith, S. Lory, A signaling network reciprocally regulates genes associated with acute infection and chronic persistence in Pseudomonas aeruginosa. Dev. Cell 7, 745-754 (2004).
5. D. Kraus, S. Herbert, S. A. Kristian, A. Khosravi, V. Nizet, F. Götz, A. Peschel, The GraRS regulatory system controls Staphylococcus aureus susceptibility to antimicrobial host defenses. BMC Microbiol. 8, 85 (2008).
6. M. Kurosu, E. Bergari, Bacterial protein kinase inhibitors. Drug Dev. Res. 71, 168-187 (2010).
7. K. Stephenson, J. A. Hoch, Virulence- and antibiotic resistance- associated two-component signal transduction systems of Gram-positive pathogenic bacteria as targets for antimicrobial therapy. Pharmacol. Ther. 93, 293-305 (2002).
8. R. O'Shea, H. E. Moser, Physicochemical properties of antibacterial compounds: implications for drug discovery. J. Med. Chem. 51, 2871-2878 (2008).
9. D. J. Payne, M. N. Gwynn, D. J. Holmes, D. L. Pompliano, Drugs for bad bugs: Confronting the challenges of antibacterial discovery. Nat. Rev. Drug Discov. 6, 29-40 (2007).
10. L. L. Silver, Challenges of antibacterial discovery. Clin. Microbiol. Rev. 24, 71-109 (2011).
11. R. Dutta, M. Inouye, GHKL, an emergent ATPase/kinase superfamily. Trends Biochem. Sci. 25, 24-28 (2000).
12. M. T. Guarnieri, L. Zhang, J. Shen, R. Zhao, The Hsp90 inhibitor radicicol interacts with the ATP-binding pocket of bacterial sensor kinase PhoQ. J. Mol. Biol. 379, 82-93 (2008).
13. T. Tanaka, S. K. Saha, C. Tomomori, R. Ishima, D. Liu, K. I. Tong, H. Park, R. Dutta, L. Qin, M. B. Swindells, T. Yamazaki, A. M. Ono, M. Kainosho, M. Inouye, M. Ikura, NMR structure of the histidine kinase domain of the E. coli osmosensor EnvZ. Nature 396, 88-92 (1998).
14. M. T. Guarnieri, B. S. Blagg, R. Zhao, A high-throughput TNP-ATP displacement assay for screening inhibitors of ATP-binding in bacterial histidine kinases. Assay Drug Dev. Technol. 9, 174-183 (2011).
15. X. Cai, J. Zhang, M. Chen, Y. Wu, X. Wang, J. Chen, J. Zhang, X. Shen, D. Qu, H. Jiang, The effect of the potential PhoQ histidine kinase inhibitors on Shigella flexneri virulence. PLoS ONE 6, e23100 (2011).
16. M. S. Butler, M. A. Cooper, Screening strategies to identify new antibiotics. Curr. Drug Targets 13, 373-387 (2012).
17. R. Gao, A. M. Stock, Probing kinase and phosphatase activities of two-component systems in vivo with concentration-dependent phosphorylation profiling. Proc. Natl. Acad. Sci. U.S.A. 110, 672-677 (2013).
18. Y. Eguchi, N. Kubo, H. Matsunaga, M. Igarashi, R. Utsumi, Development of an antivirulence drug against Streptococcus mutans: Repression of biofilm formation, acid tolerance, and competence by a histidine kinase inhibitor, walkmycin C. Antimicrob. Agents Chemother. 55, 1475-1484 (2011).
19. B. Olle, Medicines from microbiota. Nat. Biotechnol. 31, 309-315 (2013).
20. G. W. Tannock, K. Munro, C. Taylor, B. Lawley, W. Young, B. Byrne, J. Emery, T. Louie, A new macrocyclic antibiotic, fidaxomicin (OPT-80), causes less alteration to the bowel microbiota of Clostridium difficile-infected patients than does vancomycin. Microbiology 156, 3354-3359 (2010).
21. J. E. Foster, Q. Sheng, J. R. McClain, M. Bures, T. I. Nicas, K. Henry, M. E. Winkler, R. Gilmour, Kinetic and mechanistic analyses of new classes of inhibitors of two-component signal transduction systems using a coupled assay containing HpkA-DrrA from Thermotoga maritima. Microbiology 150, 885-896 (2004).
22. J. M. Kee, R. C. Oslund, D. H. Perlman, T. W. Muir, A pan-specific antibody for direct detection of protein histidine phosphorylation. Nat. Chem. Biol. 9, 416-421 (2013).
23. D. A. Rasko, C. G. Moreira, R. Li, N. C. Reading, J. M. Ritchie, M. K. Waldor, N. Williams, R. Taussig, S. Wei, M. Roth, D. T. Hughes, J. F. Huntley, M. W. Fina, J. R. Falck, V. Sperandio, Targeting QseC signaling and virulence for antibiotic development. Science 321, 1078-1080 (2008).
24. K. E. Wilke, S. Francis, E. E. Carlson, Activity-based probe for histidine kinase signaling. J. Am. Chem. Soc. 134, 9150-9153 (2012).
25. A. Marina, C. Mott, A. Auyzenberg, W. A. Hendrickson, C. D. Waldburger, Structural and mutational analysis of the PhoQ histidine kinase catalytic domain. Insight into the reaction mechanism. J. Biol. Chem. 276, 41182-41190 (2001).
26. A. M. Bilwes, C. M. Quezada, L. R. Croal, B. R. Crane, M. I. Simon, Nucleotide binding by the histidine kinase CheA. Nat. Struct. Biol. 8, 353-360 (2001).